{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Cancer outpatients", "Cancer treatment", "Chemotherapy", "Complementary and alternative medicine", "Drug\u2013drug interactions", "Food\u2013drug interactions"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "33864520", "DateCompleted": {"Year": "2022", "Month": "02", "Day": "07"}, "DateRevised": {"Year": "2022", "Month": "02", "Day": "18"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "04", "Day": "17"}], "Language": ["eng"], "ELocationID": ["10.1007/s00432-021-03625-3"], "Journal": {"ISSN": "1432-1335", "JournalIssue": {"Volume": "148", "Issue": "2", "PubDate": {"Year": "2022", "Month": "Feb"}}, "Title": "Journal of cancer research and clinical oncology", "ISOAbbreviation": "J Cancer Res Clin Oncol"}, "ArticleTitle": "Interactions in cancer treatment considering cancer therapy, concomitant medications, food, herbal medicine and other supplements.", "Pagination": {"StartPage": "461", "EndPage": "473", "MedlinePgn": "461-473"}, "Abstract": {"AbstractText": ["The aim of our study was to analyse the frequency and severity of different types of potential interactions in oncological outpatients' therapy. Therefore, medications, food and substances in terms of complementary and alternative medicine (CAM) like dietary supplements, herbs and other processed ingredients were considered.", "We obtained data from questionnaires and from analysing the patient records of 115 cancer outpatients treated at a German university hospital. Drug-drug interactions were identified using a drug interaction checking software. Potential CAM-drug interactions and food-drug interactions were identified based on literature research.", "92.2% of all patients were at risk of one or more interaction of any kind and 61.7% of at least one major drug-drug interaction. On average, physicians prescribed 10.4 drugs to each patient and 6.9 interactions were found, 2.5 of which were classified as major. The most prevalent types of drug-drug interactions were a combination of QT prolonging drugs (32.3%) and drugs with a potential for myelotoxicity (13.4%) or hepatotoxicity (10.1%). In 37.2% of all patients using CAM supplements the likelihood of interactions with medications was rated as likely. Food-drug interactions were likely in 28.7% of all patients.", "The high amount of interactions could not be found in literature so far. We recommend running interaction checks when prescribing any new drug and capturing CAM supplements in medication lists too. If not advised explicitly in another way drugs should be taken separately from meals and by using nonmineralized water to minimize the risk for food-drug interactions."], "CopyrightInformation": "\u00a9 2021. The Author(s)."}, "AuthorList": [{"Identifier": ["0000-0002-5429-2008"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Klinik f\u00fcr Innere Medizin II, H\u00e4matologie und Internistische Onkologie, Universit\u00e4tsklinikum Jena, Am Klinikum 1, 07747, Jena, Germany. clemens.wolf@uni-jena.de."}], "LastName": "Wolf", "ForeName": "Clemens P J G", "Initials": "CPJG"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Klinik f\u00fcr Innere Medizin II, H\u00e4matologie und Internistische Onkologie, Pneumologie, Universit\u00e4tsklinikum Jena, Am Klinikum 1, 07747, Jena, Germany."}], "LastName": "Rachow", "ForeName": "Tobias", "Initials": "T"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Klinik f\u00fcr Innere Medizin II, H\u00e4matologie und Internistische Onkologie, Konservative Tagesklinik des Universit\u00e4tsTumorCentrums (UTC), Universit\u00e4tsklinikum Jena, Am Klinikum 1, 07747, Jena, Germany."}], "LastName": "Ernst", "ForeName": "Thomas", "Initials": "T"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Klinik f\u00fcr Innere Medizin II, H\u00e4matologie und Internistische Onkologie, Universit\u00e4tsklinikum Jena, Am Klinikum 1, 07747, Jena, Germany."}], "LastName": "Hochhaus", "ForeName": "Andreas", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Onkologische Kooperation Harz, K\u00f6sliner Stra\u00dfe 14, 38642, Goslar, Germany."}], "LastName": "Zomorodbakhsch", "ForeName": "Bijan", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Klinik f\u00fcr Urologie, Universit\u00e4tsklinikum Jena, Am Klinikum 1, 07747, Jena, Germany."}], "LastName": "Foller", "ForeName": "Susan", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Klinik und Poliklinik f\u00fcr Frauenheilkunde und Fortpflanzungsmedizin, Universit\u00e4tsklinikum Jena, Am Klinikum 1, 07747, Jena, Germany."}], "LastName": "Rengsberger", "ForeName": "Matthias", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Apotheke des Universit\u00e4tsklinikums, Universit\u00e4tsklinikum Jena, Am Klinikum 1, 07747, Jena, Germany."}], "LastName": "Hartmann", "ForeName": "Michael", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Klinik f\u00fcr Innere Medizin II, H\u00e4matologie und Internistische Onkologie, Integrative Onkologie, Universit\u00e4tsklinikum Jena, Am Klinikum 1, 07747, Jena, Germany."}], "LastName": "H\u00fcbner", "ForeName": "Jutta", "Initials": "J"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Germany", "MedlineTA": "J Cancer Res Clin Oncol", "NlmUniqueID": "7902060", "ISSNLinking": "0171-5216"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Adolescent"}, {"QualifierName": [], "DescriptorName": "Adult"}, {"QualifierName": [], "DescriptorName": "Aged"}, {"QualifierName": [], "DescriptorName": "Aged, 80 and over"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Antineoplastic Combined Chemotherapy Protocols"}, {"QualifierName": ["statistics & numerical data"], "DescriptorName": "Complementary Therapies"}, {"QualifierName": ["adverse effects", "statistics & numerical data"], "DescriptorName": "Dietary Supplements"}, {"QualifierName": [], "DescriptorName": "Drug Interactions"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": ["physiology"], "DescriptorName": "Food-Drug Interactions"}, {"QualifierName": ["epidemiology"], "DescriptorName": "Germany"}, {"QualifierName": [], "DescriptorName": "Herbal Medicine"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Middle Aged"}, {"QualifierName": ["drug therapy", "epidemiology", "pathology"], "DescriptorName": "Neoplasms"}, {"QualifierName": ["adverse effects", "methods"], "DescriptorName": "Phytotherapy"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Plant Extracts"}, {"QualifierName": ["adverse effects"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["statistics & numerical data"], "DescriptorName": "Polypharmacy"}, {"QualifierName": [], "DescriptorName": "Retrospective Studies"}, {"QualifierName": [], "DescriptorName": "Surveys and Questionnaires"}, {"QualifierName": [], "DescriptorName": "Young Adult"}], "CoiStatement": "The authors declare that they have no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Abbas S, Ihle P, Harder S, Schubert I. Risk of hyperkalemia and combined use of spironolactone and long-term ACE inhibitor/angiotensin receptor blocker therapy in heart failure using real-life data: a population- and insurance-based cohort. Pharmacoepidemiol Drug Saf. 2015;24(4):406\u2013413. doi: 10.1002/pds.3748.", "ArticleIdList": ["10.1002/pds.3748", "25683504"]}, {"Citation": "AbZ-Pharma GmbH (2019) Fachinformation Metamizol AbZ 500 mg Tabletten. AbZ-Pharma GmbH. https://www.fachinfo.de/api/fachinfo/pdf/013816. Accessed 19 Feb 2021"}, {"Citation": "AbZ-Pharma GmbH (2020) Fachinformation Pantoprazol AbZ 40 mg magensaftresistente Tabletten. AbZ-Pharma GmbH. https://www.fachinfo.de/api/fachinfo/pdf/020161. Accessed 19 Feb 2021"}, {"Citation": "Al-Jenoobi FI, Al-Thukair AA, Abbas FA, Ansari MJ, Alkharfy KM, Al-Mohizea AM, Al-Suwayeh SA, Jamil S. Effect of black seed on dextromethorphan O- and N-demethylation in human liver microsomes and healthy human subjects. Drug Metab Lett. 2010;4(1):51\u201355. doi: 10.2174/187231210790980435.", "ArticleIdList": ["10.2174/187231210790980435", "20201775"]}, {"Citation": "Alsanad SM, Howard RL, Williamson EM. An assessment of the impact of herb-drug combinations used by cancer patients. BMC Complement Altern Med. 2016;16(1):393. doi: 10.1186/s12906-016-1372-x.", "ArticleIdList": ["10.1186/s12906-016-1372-x", "PMC5070090", "27756298"]}, {"Citation": "Altmann D, Eggmann U, Ammann P. Drug induced QT prolongation. Wien Klin Wochenschr. 2008;120(5\u20136):128\u2013135. doi: 10.1007/s00508-008-0940-6.", "ArticleIdList": ["10.1007/s00508-008-0940-6", "18365152"]}, {"Citation": "Arzneimittelbrief (2016) Die Behandlung alter Menschen mit Antipsychotika und Antidepressiva ist mit einem erh\u00f6hten Sterberisiko assoziiert. Arzneimittelbrief 50(37):5. https://der-arzneimittelbrief.de/de/textdateiupload/2016,50,37_9895.pdf. Accessed 27 Nov 2020"}, {"Citation": "Bailey DG, Dresser G, Arnold JMO. Grapefruit-medication interactions: forbidden fruit or avoidable consequences? CMAJ. 2013;185(4):309\u2013316. doi: 10.1503/cmaj.120951.", "ArticleIdList": ["10.1503/cmaj.120951", "PMC3589309", "23184849"]}, {"Citation": "Benvenga S, Di Bari F, Vita R. Undertreated hypothyroidism due to calcium or iron supplementation corrected by oral liquid levothyroxine. Endocrine. 2017;56(1):138\u2013145. doi: 10.1007/s12020-017-1244-2.", "ArticleIdList": ["10.1007/s12020-017-1244-2", "28155174"]}, {"Citation": "Castro-Manzanares M, do Pazo-Oubi\u00f1a F, Rodr\u00edguez-Rinc\u00f3n RM. Prevalence of potential drug\u2013drug interactions in outpatients on treatment with parenteral antineoplastic drugs. Int J Clin Pharm. 2019;41(6):1429\u20131433. doi: 10.1007/s11096-019-00910-7.", "ArticleIdList": ["10.1007/s11096-019-00910-7", "31538281"]}, {"Citation": "Cho H-J, Yoon I-S. Pharmacokinetic interactions of herbs with cytochrome P450 and P-Glycoprotein. Evidence-Based Complement Alternat Med. 2015;2015:736431. doi: 10.1155/2015/736431.", "ArticleIdList": ["10.1155/2015/736431", "PMC4302358", "25632290"]}, {"Citation": "Chung JH, Choi DH, Choi JS. Effects of oral epigallocatechin gallate on the oral pharmacokinetics of verapamil in rats. Biopharm Drug Dispos. 2009;30(2):90\u201393. doi: 10.1002/bdd.644.", "ArticleIdList": ["10.1002/bdd.644", "19226653"]}, {"Citation": "Dixit A, Majumdar G, Tewari P. Hyperkalemia in ambulant postcardiac surgery patients during combined therapy with angiotensin-converting enzyme inhibitor, spironolactone, and diet rich in potassium: a report of two cases and review of literature. Ann Card Anaesth. 2019;22(2):162\u2013168. doi: 10.4103/aca.ACA_65_18.", "ArticleIdList": ["10.4103/aca.ACA_65_18", "PMC6489390", "30971598"]}, {"Citation": "El-Sabawi D, Abu-Dahab R, Zalloum WA, Ijbara F, Hamdan II. The effect of ferrous ions, calcium ions and citric acid on absorption of ciprofloxacin across caco-2 cells: practical and structural approach. Drug Dev Ind Pharm. 2019;45(2):292\u2013303. doi: 10.1080/03639045.2018.1539495.", "ArticleIdList": ["10.1080/03639045.2018.1539495", "30348012"]}, {"Citation": "Engdal S, Nilsen OG. In vitro inhibition of CYP3A4 by herbal remedies frequently used by cancer patients. Phytother Res. 2009;23(7):906\u2013912. doi: 10.1002/ptr.2750.", "ArticleIdList": ["10.1002/ptr.2750", "19170155"]}, {"Citation": "Fruzza AG, Demeterco-Berggren C, Jones KL. Unawareness of the effects of soy intake on the management of congenital hypothyroidism. Pediatrics. 2012;130(3):e699\u2013702. doi: 10.1542/peds.2011-3350.", "ArticleIdList": ["10.1542/peds.2011-3350", "22908106"]}, {"Citation": "Garc\u00eda-Cort\u00e9s M, Robles-D\u00edaz M, Ortega-Alonso A, Medina-Caliz I, Andrade RJ. Hepatotoxicity by dietary supplements: a tabular listing and clinical characteristics. Int J Mol Sci. 2016;17(4):537. doi: 10.3390/ijms17040537.", "ArticleIdList": ["10.3390/ijms17040537", "PMC4848993", "27070596"]}, {"Citation": "Golden EB, Lam PY, Kardosh A, Gaffney KJ, Cadenas E, Louie SG, Petasis NA, Chen TC, Sch\u00f6nthal AH. Green tea polyphenols block the anticancer effects of bortezomib and other boronic acid-based proteasome inhibitors. Blood. 2009;113(23):5927\u20135937. doi: 10.1182/blood-2008-07-171389.", "ArticleIdList": ["10.1182/blood-2008-07-171389", "19190249"]}, {"Citation": "G\u00f3rska-Warsewicz H, Rejman K, Laskowski W, Kowalcze K. Food sources of potassium in the average polish diet. Nutrients. 2019 doi: 10.3390/nu11122905.", "ArticleIdList": ["10.3390/nu11122905", "PMC6950722", "31805745"]}, {"Citation": "Gouraud A, Vochelle V, Descotes J, Vial T. Proton pump inhibitor-induced neutropenia: possible cross-reactivity between omeprazole and pantoprazole. Clin Drug Investig. 2010;30(8):559\u2013563. doi: 10.2165/11537230-000000000-00000.", "ArticleIdList": ["10.2165/11537230-000000000-00000", "20586518"]}, {"Citation": "Heaney ML, Gardner JR, Karasavvas N, Golde DW, Scheinberg DA, Smith EA, O'Connor OA. Vitamin C antagonizes the cytotoxic effects of antineoplastic drugs. Cancer Res. 2008;68(19):8031\u20138038. doi: 10.1158/0008-5472.Can-08-1490.", "ArticleIdList": ["10.1158/0008-5472.Can-08-1490", "PMC3695824", "18829561"]}, {"Citation": "Herbold N, Edelstein S. Rapid reference for nurses: nutrition. Sudbury: Jones & Bartlett Learning; 2008."}, {"Citation": "HEUMANN PHARMA GmbH & Co. Generica KG (2019) Fachinformation Metamizol Heumann 500 mg Tabletten. HEUMANN PHARMA GmbH & Co. Generica KG. https://www.fachinfo.de/api/fachinfo/pdf/021278. Accessed 19 Feb 2021"}, {"Citation": "Hodges PJ, Kam PC. The peri-operative implications of herbal medicines. Anaesthesia. 2002;57(9):889\u2013899. doi: 10.1046/j.1365-2044.2002.02781.x.", "ArticleIdList": ["10.1046/j.1365-2044.2002.02781.x", "12190754"]}, {"Citation": "Hoemme A, Barth H, Haschke M, Kraehenbuehl S, Strasser F, Lehner C, von Kameke A, Waelti T, Thuerlimann B, Frueh M, Driessen C, Joerger M. Prognostic impact of polypharmacy and drug interactions in patients with advanced cancer. Cancer Chemother Pharmacol. 2019;83(4):763\u2013774. doi: 10.1007/s00280-019-03783-9.", "ArticleIdList": ["10.1007/s00280-019-03783-9", "30684020"]}, {"Citation": "Huebner J. Komplement\u00e4re Onkologie: supportive Ma\u00dfnahmen und evidenzbasierte Empfehlungen. Stuttgart: Schattauer; 2012."}, {"Citation": "JANSSEN-CILAG INTERNATIONAL NV (2019) Fachinformation VELCADE\u00ae 3,5 mg Pulver. JANSSEN-CILAG INTERNATIONAL NV. https://www.fachinfo.de/api/fachinfo/pdf/008387. Accessed 19 Feb 2021"}, {"Citation": "Kim IS, Kim SY, Yoo HH. Effects of an aqueous-ethanolic extract of ginger on cytochrome P450 enzyme-mediated drug metabolism. Pharmazie. 2012;67(12):1007\u20131009. doi: 10.1691/ph.2012.2595.", "ArticleIdList": ["10.1691/ph.2012.2595", "23346764"]}, {"Citation": "Kimura Y, Ito H, Hatano T. Effects of mace and nutmeg on human cytochrome P450 3A4 and 2C9 activity. Biol Pharm Bull. 2010;33(12):1977\u20131982. doi: 10.1248/bpb.33.1977.", "ArticleIdList": ["10.1248/bpb.33.1977", "21139236"]}, {"Citation": "LHRM e.V. (2014) Bortezomib (Velcade\u00ae): Wissenswertes f\u00fcr Patientinnen, Patienten und ihre Angeh\u00f6rigen. Leuk\u00e4miehilfe RHEIN-MAIN (LHRM) e. V. https://www.myelom-deutschland.de/wp-content/uploads/2016/07/MD_Broschueren_Bortezomib.pdf. Accessed 19 Feb 2021"}, {"Citation": "Liede KE, Haukka JK, Sax\u00e9n LM, Heinonen OP. Increased tendency towards gingival bleeding caused by joint effect of alpha-tocopherol supplementation and acetylsalicylic acid. Ann Med. 1998;30(6):542\u2013546. doi: 10.3109/07853899709002602.", "ArticleIdList": ["10.3109/07853899709002602", "9920356"]}, {"Citation": "Mazzanti G, Menniti-Ippolito F, Moro PA, Cassetti F, Raschetti R, Santuccio C, Mastrangelo S. Hepatotoxicity from green tea: a review of the literature and two unpublished cases. Eur J Clin Pharmacol. 2009;65(4):331\u2013341. doi: 10.1007/s00228-008-0610-7.", "ArticleIdList": ["10.1007/s00228-008-0610-7", "19198822"]}, {"Citation": "Molassiotis A, Fern\u00e1ndez-Ortega P, Pud D, Ozden G, Scott JA, Panteli V, Margulies A, Browall M, Magri M, Selvekerova S, Madsen E, Milovics L, Bruyns I, Gudmundsdottir G, Hummerston S, Ahmad AM-A, Platin N, Kearney N, Patiraki E. Use of complementary and alternative medicine in cancer patients: a European survey. Ann Oncol. 2005;16(4):655\u2013663. doi: 10.1093/annonc/mdi110.", "ArticleIdList": ["10.1093/annonc/mdi110", "15699021"]}, {"Citation": "Naing A, Stephen SK, Frenkel M, Chandhasin C, Hong DS, Lei X, Falchook G, Wheler JJ, Fu S, Kurzrock R. Prevalence of complementary medicine use in a phase 1 clinical trials program: the MD Anderson Cancer Center Experience. Cancer. 2011;117(22):5142\u20135150. doi: 10.1002/cncr.26164.", "ArticleIdList": ["10.1002/cncr.26164", "21538342"]}, {"Citation": "Neuvonen PJ, Kivist\u00f6 KT, Lehto P. Interference of dairy products with the absorption of ciprofloxacin. Clin Pharmacol Ther. 1991;50(5 Pt 1):498\u2013502. doi: 10.1038/clpt.1991.174.", "ArticleIdList": ["10.1038/clpt.1991.174", "1934862"]}, {"Citation": "Ozkan MC, Donmez A, Arslan A, Aydemir S, Tombuloglu M (2015) Use of proton pump inhibitors in hematopoietic stem cell transplantation does not increase the frequency of febrile neutropenia. Eur Rev Med Pharmacol Sci 19(21):4105\u20134110. https://www.europeanreview.org/article/9767. Accessed 19 Feb 2021", "ArticleIdList": ["26592835"]}, {"Citation": "Pae HO, Oh GS, Seo WG, Shin MK, Hong SG, Lee HS, Chung HT. Mistletoe lectin synergizes with paclitaxel in human SK-hep1 hepatocarcinoma cells. Immunopharmacol Immunotoxicol. 2001;23(4):531\u2013540. doi: 10.1081/iph-100108599.", "ArticleIdList": ["10.1081/iph-100108599", "11792012"]}, {"Citation": "Perrone G, Hideshima T, Ikeda H, Okawa Y, Calabrese E, Gorgun G, Santo L, Cirstea D, Raje N, Chauhan D, Baccarani M, Cavo M, Anderson KC. Ascorbic acid inhibits antitumor activity of bortezomib in vivo. Leukemia. 2009;23(9):1679\u20131686. doi: 10.1038/leu.2009.83.", "ArticleIdList": ["10.1038/leu.2009.83", "19369963"]}, {"Citation": "Petri H. Das Interaktionspotenzial konventioneller Zytostatika. Dtsch Arztebl. 2017;114(48):19\u201321. doi: 10.3238/PersOnko/2017.12.01.04.", "ArticleIdList": ["10.3238/PersOnko/2017.12.01.04"]}, {"Citation": "Qiu J-X, Zhou Z-W, He Z-X, Zhang X, Zhou S-F, Zhu S. Estimation of the binding modes with important human cytochrome P450 enzymes, drug interaction potential, pharmacokinetics, and hepatotoxicity of ginger components using molecular docking, computational, and pharmacokinetic modeling studies. Drug Des Devel Ther. 2015;9:841\u2013866. doi: 10.2147/DDDT.S74669.", "ArticleIdList": ["10.2147/DDDT.S74669", "PMC4338259", "25733806"]}, {"Citation": "Ratiopharm GmbH (2020a) Dexamethason-ratiopharm 4 mg/8 mg Tabletten. ratiopharm GmbH. https://www.fachinfo.de/api/fachinfo/pdf/008836. Accessed 19 Feb 2021"}, {"Citation": "Ratiopharm GmbH (2020b) Fachinformation Pantoprazol-ratiopharm\u00ae 40 mg magensaftresistente Tabletten. ratiopharm GmbH. https://www.fachinfo.de/api/fachinfo/pdf/020160. Accessed 19 Feb 2021"}, {"Citation": "Robert Koch-Institut, Gesellschaft der epidemiologischen Krebsregister in Deutschland e.V. (2019) Krebs in Deutschland 2015/2016. Krebs in Deutschland 12. 10.25646/5977.2"}, {"Citation": "Schaefer L, Baron von Osthoff M, Huebner J. Potential interactions of medication prescribed in discharge letters from a clinic for hematology and oncology. Oncol Res Treat. 2018;41:200\u2013205. doi: 10.1159/000486161.", "ArticleIdList": ["10.1159/000486161", "29558757"]}, {"Citation": "Shah JJ, Kuhn DJ, Orlowski RZ. Bortezomib and EGCG: no green tea for you? Blood. 2009;113(23):5695\u20135696. doi: 10.1182/blood-2009-03-204776.", "ArticleIdList": ["10.1182/blood-2009-03-204776", "PMC2700310", "19498025"]}, {"Citation": "Shalansky S, Lynd L, Richardson K, Ingaszewski A, Kerr C. Risk of warfarin-related bleeding events and supratherapeutic international normalized ratios associated with complementary and alternative medicine: a longitudinal analysis. Pharmacotherapy. 2007;27(9):1237\u20131247. doi: 10.1592/phco.27.9.1237.", "ArticleIdList": ["10.1592/phco.27.9.1237", "17723077"]}, {"Citation": "Shin SC, Choi JS. Effects of epigallocatechin gallate on the oral bioavailability and pharmacokinetics of tamoxifen and its main metabolite, 4-hydroxytamoxifen, in rats. Anticancer Drugs. 2009;20(7):584\u2013588. doi: 10.1097/CAD.0b013e32832d6834.", "ArticleIdList": ["10.1097/CAD.0b013e32832d6834", "19491656"]}, {"Citation": "Skelin M, Lucijani\u0107 T, Amid\u017ei\u0107 Klari\u0107 D, Re\u0161i\u0107 A, Bakula M, Liberati-\u010cizmek AM, Gharib H, Raheli\u0107 D. Factors affecting gastrointestinal absorption of levothyroxine: a review. Clin Ther. 2017;39(2):378\u2013403. doi: 10.1016/j.clinthera.2017.01.005.", "ArticleIdList": ["10.1016/j.clinthera.2017.01.005", "28153426"]}, {"Citation": "Suekawa M, Ishige A, Yuasa K, Sudo K, Aburada M, Hosoya E. Pharmacological studies on ginger. I. Pharmacological actions of pungent constitutents, (6)-gingerol and (6)-shogaol. J Pharmacobiodyn. 1984;7(11):836\u2013848. doi: 10.1248/bpb1978.7.836.", "ArticleIdList": ["10.1248/bpb1978.7.836", "6335723"]}, {"Citation": "Usman M, Davidson J, Books MC. Health benefits of beetroot. Mendon: Mendon Cottage Books; 2015."}, {"Citation": "Walker RC, Wright AJ. The fluoroquinolones. Mayo Clin Proc. 1991;66(12):1249\u20131259. doi: 10.1016/s0025-6196(12)62477-x.", "ArticleIdList": ["10.1016/s0025-6196(12)62477-x", "1749294"]}, {"Citation": "Wei R, Hu Y, Xiong J. Effect size reporting practices in applied linguistics research: a study of one major journal. SAGE Open. 2019 doi: 10.1177/2158244019850035.", "ArticleIdList": ["10.1177/2158244019850035"]}, {"Citation": "Wode K, Henriksson R, Sharp L, Stoltenberg A, H\u00f6k Nordberg J. Cancer patients\u2019 use of complementary and alternative medicine in Sweden: a cross-sectional study. BMC Complement Altern Med. 2019;19(1):62. doi: 10.1186/s12906-019-2452-5.", "ArticleIdList": ["10.1186/s12906-019-2452-5", "PMC6417272", "30866916"]}, {"Citation": "World Health Organization . The safety of medicines in public health programmes: pharmacovigilance an essential tool. Geneva: World Health Organization; 2006."}, {"Citation": "Yang CT, Kor CT, Hsieh YP. Long-term effects of spironolactone on kidney function and hyperkalemia-associated hospitalization in patients. J Clin Med. 2018 doi: 10.3390/jcm7110459.", "ArticleIdList": ["10.3390/jcm7110459", "PMC6262621", "30469400"]}, {"Citation": "Yu Z, Hu J, Hu Y. Neutropenia and thrombocytopenia induced by proton pump inhibitors: a case report. Drug Saf Case Rep. 2018;5(1):28. doi: 10.1007/s40800-018-0093-0.", "ArticleIdList": ["10.1007/s40800-018-0093-0", "PMC6251937", "30470925"]}, {"Citation": "Zeller T, Muenstedt K, Stoll C, Schweder J, Senf B, Ruckhaeberle E, Becker S, Serve H, Huebner J. Potential interactions of complementary and alternative medicine with cancer therapy in outpatients with gynecological cancer in a comprehensive cancer center. J Cancer Res Clin Oncol. 2013;139(3):357\u2013365. doi: 10.1007/s00432-012-1336-6.", "ArticleIdList": ["10.1007/s00432-012-1336-6", "23099993"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "2", "Day": "19"}, {"Year": "2021", "Month": "3", "Day": "29"}, {"Year": "2021", "Month": "4", "Day": "18", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "2", "Day": "8", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "4", "Day": "17", "Hour": "12", "Minute": "7"}, {"Year": "2021", "Month": "4", "Day": "17"}], "PublicationStatus": "ppublish", "ArticleIdList": ["33864520", "PMC8800918", "10.1007/s00432-021-03625-3", "10.1007/s00432-021-03625-3"]}}], "PubmedBookArticle": []}